PlatoScience
1 known investors
PlatoScience develops wireless, at-home transcranial direct current stimulation (tDCS) headsets and remote-management software for clinicians, researchers, and patients. Its products include PlatoCare, approved for treating depression in the EU and UK, and PlatoWork for general tDCS use in markets such as the US, Turkey, and Malaysia.
Investors · 1
Frequently asked questions
- What does PlatoScience do?
- PlatoScience develops wireless, at-home transcranial direct current stimulation (tDCS) headsets and remote-management software for clinicians, researchers, and patients. Its products include PlatoCare, approved for treating depression in the EU and UK, and PlatoWork for general tDCS use in markets such as the US, Turkey, and Malaysia.
- Who are PlatoScience's investors?
- PlatoScience's investors include Btomorrow Ventures.